CIK 0001515673 · Large accelerated filer
Ultragenyx Pharmaceutical Inc.
Sign in to watch- Ticker
- RARE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 272546083
- Phone
- 415-483-8800
- Business address
- 60 LEVERONI COURT, NOVATO, CA, 94949
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $127,561
- in 3 filings, $17K under 10b5-1 plans
Net −$127,561. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-01 | Horn Howard Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +34,200 | 34,200 | ||
| 2024-03-01 | Parschauer Karah Herdman EVP and Chief Legal Officer | Grant or award | +17,800 | 69,782 | ||
| 2024-03-01 | Parschauer Karah Herdman EVP and Chief Legal Officer | Grant or award | +957 | 70,739 | ||
| 2024-03-01 | Parschauer Karah Herdman EVP and Chief Legal Officer | Sale | −3,756 | $53.76 | $202K | 67,340 |
| 2024-03-01 | Parschauer Karah Herdman EVP and Chief Legal Officer | Grant or award · Stock Option (Right to Buy) | +31,400 | 31,400 | ||
| 2024-03-01 | Kassberg Thomas Richard CBO & EVP | Grant or award | +17,800 | 264,660 | ||
| 2024-03-01 | Kassberg Thomas Richard CBO & EVP | Grant or award | +957 | 265,617 | ||
| 2024-03-01 | Kassberg Thomas Richard CBO & EVP | Shares withheld for taxes | −274 | $53.69 | $15K | 265,343 |
| 2024-03-01 | Kassberg Thomas Richard CBO & EVP | Sale | −1,011 | $53.76 | $54K | 264,332 |
| 2024-03-01 | Kassberg Thomas Richard CBO & EVP | Grant or award · Stock Option (Right to Buy) | +31,400 | 31,400 | ||
| 2024-03-01 | Huang Dennis Karl See Remarks | Grant or award | +17,800 | 82,515 | ||
| 2024-03-01 | Huang Dennis Karl See Remarks | Grant or award | +957 | 83,472 | ||
| 2024-03-01 | Huang Dennis Karl See Remarks | Shares withheld for taxes | −470 | $53.69 | $25K | 83,002 |
| 2024-03-01 | Huang Dennis Karl See Remarks | Grant or award · Stock Option (Right to Buy) | +31,400 | 31,400 | ||
| 2024-03-01 | Pinion John Richard See Remarks | Grant or award | +17,800 | 92,544 | ||
| 2024-03-01 | Pinion John Richard See Remarks | Grant or award | +957 | 93,501 | ||
| 2024-03-01 | Pinion John Richard See Remarks | Shares withheld for taxes | −60 | $53.69 | $3K | 93,441 |
| 2024-03-01 | Pinion John Richard See Remarks | Sale | −4,173 | $53.76 | $224K | 89,268 |
| 2024-03-01 | Pinion John Richard See Remarks | Grant or award · Stock Option (Right to Buy) | +31,400 | 31,400 | ||
| 2024-03-01 | Huizenga Theodore Alan SVP, Chief Accounting Officer | Grant or award | +13,950 | 41,842 |
Page 9 of 11 · 204 trades